You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

30 search results for: diagnosis

expert video

GOLD 2024 Diagnosis and Assessment of COPD

10 min

Pulmonology

This short video presentation outlines the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals.

Impact of Delayed EoE <b>Diagnosis</b> on Disease Progression and QoL

expert video

Impact of Delayed EoE Diagnosis on Disease Progression and QoL

2 min

Gastroenterology

Join Prof. Arjan Bredenoord as he discusses the importance of early diagnosis of EoE.

The Journey to <b>Diagnosis</b>: Considerations For AD, PN, and CSU

expert video

The Journey to Diagnosis: Considerations For AD, PN, and CSU

14 min

Dermatology

In this symposium from Fall Clinical 2023, join Drs. James Q. Del Rosso and Raj Chovatiya as they explore the journey to diagnosis of type 2 inflammation in AD, PN, and CSU.

ADVENT On Air | Getting to the <b>Diagnosis</b> of AD in Pediatric Patients

audio

ADVENT On Air | Getting to the Diagnosis of AD in Pediatric Patients

15 min

Dermatology

Learn more about the journey to diagnosis for pediatric patients with AD in this conversation between Drs. Lisa Swanson and Weily Soong.

expert video

Clinical Assessment of Prurigo Nodularis

9 min

Dermatology

Join Dr. Nicholas Mollanazar as he discusses the diagnosis and assessment of prurigo nodularis.

expert video

The Journey of Diagnosis: Disease Burden and Diagnostic Considerations for Atopic Dermatitis and Prurigo Nodularis

30 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations and challenges associated with atopic dermatitis and prurigo nodularis.

interactivity

Eosinophilic Esophagitis (EoE) Interactive Patient Case

10 min

Gastroenterology

Learn about the guidelines for diagnosis, treatment options, and criteria for treatment response in EoE through the journey of a hypothetical EoE patient.

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and <b>Diagnosis</b>

audio

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

12 min

Gastroenterology

Hear Dr. Wechsler and Prof. Bredenoord discuss the multifaceted burden of EoE and how to overcome challenges in identifying EoE in clinical practice.

expert video

AD and PN: Diagnosis and Impact on Quality of Life

1 min

Dermatology

Approaches to diagnosis and the multidimensional burden of atopic dermatitis and prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.

videoanimation

Prurigo Nodularis: The Patient Journey

2 min

Dermatology

An educational video highlighting the disease burden and impact of prurigo nodularis and describing the patient journey before diagnosis and beyond.

EAACI 2022 | Unmet Needs in the <b>Diagnosis</b> and Management of Chronic Urticaria

expert video

EAACI 2022 | Unmet Needs in the Diagnosis and Management of Chronic Urticaria

10 min

Dermatology

Join Dr. Autumn Burnette as she discusses the unmet needs in the diagnosis and management of chronic urticaria.

videoanimation

The Burden of Chronic Spontaneous Urticaria

5 min

Dermatology

Learn about the clinical presentation of CSU and the burden many CSU patients face by following one patient’s journey from symptom presentation to CSU diagnosis.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region